The bronchoprotective effect of inhaled salmeterol in preschool children: A dose-ranging study

European Respiratory Journal

Volumn 13, Issue 1, 1999, Pages 78-81

  Primhak, R A ^a   Smith, C M ^a   Yong, S C ^a   Wach, R ^a   Kurian, M ^a   Brown, R ^b   Efthimiou, J ^b  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Bronchial responsiveness; Infants; Salmeterol

Indexed keywords

METHACHOLINE; PLACEBO; SALMETEROL;

ARTERIAL OXYGEN SATURATION; ARTICLE; BRONCHUS REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; HUMAN; INFANT; INHALATIONAL DRUG ADMINISTRATION; MALE; METERED DOSE INHALER; PRESCHOOL CHILD; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; WHEEZING;

ADMINISTRATION, INHALATION; ALBUTEROL; BRONCHODILATOR AGENTS; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFANT; MALE; RESPIRATORY SOUNDS;

EID: 0033023739     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.99.13107199     Document Type: Article

References (29)

1. Green CP, Price JF. Prevention of exercise induced asthma by inhaled salmeterol xinafoate. Arch Dis Childhood 1992; 67: 1014-1017.
2. Lenney W, Pedersen S, Boner AL, Ebbutt A, Jenkins MM. Efficacy and safety of salmeterol in childhood asthma. Eur J Pediatr 1995; 154: 983-990.
3. Sarin S, Shami S, Cheatle T. Salmeterol in nocturnal asthma. Br Med J 1991; 302: 347-348.
4. Simons FE, Soni NR, Watson WT, Backer AB. Bronchodilator and bronchoprotective effects of salmeterol in young patients with asthma. J Allergv Clin Immunol 1992; 90: 840-846.
5. Britton M, Earnshaw J, Palmer J. A twelve-months comparison of salmeterol with salbutamol in asthmatic patients. Eur Respir J 1992; 5: 1062-1067.
6. British Thoracic Society. National Asthma Campaign, Royal College of Physicians of London, British Association of Accident and Emergency Medicine, British Paediatric Respiratory Society, Royal College of Paediatrics and Child Health. The British guidelines on asthma management. 1995 review and position statement. Thorax 1997; 52: 1-21.
7. Avital A, Bar Yishay E, Springer C, Godfrey S. Bronchial provocation tests in young children using tracheal auscultation. J Pediatr 1988; 112: 591-594.
8. 2 agonist. Br Med J 1990; 301: 1365-1368.
9. Carlsen KH, Roksund O, Olsholt K, Nja F, Leegaard J, Bratten G. Overnight protection by inhaled salmeterol on exercise-induced asthma in children. Eur Respir J 1995; 8: 1852-1855.
10. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group (see comments). Lancet 1994; 344: 219-224.
11. Noviski N. Cohen L, Springer C, Bur Yishay E, Avital A. Godfrey S. Bronchial provocation determined by breath sounds compared with lung function. Arch Dis Childhood 1991; 66: 952-955.
12. Wilson N, Bridge P, Phagoo S, Silverman M. The measurement of methacholine responsiveness in 5 year old children: three methods compared. Eur Respir J 1995; 8: 364-370.
13. Lenney W, Milner AD. At what age do bronchodilator drugs work? Arch Dis Childhood 1978; 53: 532-535.
14. Prahl P, Petersen NT, Hornsleth A. Beta 2-agonists for the treatment of wheezy bronchitis? Ann Allergy 1986; 57: 439-441.
15. Alario AJ, Lewander WJ, Dennehy P, Seifer R, Mansell AL. The efficacy of nebulized metaproterenol in wheezing infants and young children. Am J Dis Children 1992; 146: 412-418.
16. Bentur L, Kerem E, Canny G, et al. Response of acute asthma to a beta 2 agonist in children less than two years of age. Ann Allergy 1990; 65: 122-126.
17. Bentur L, Canny GJ, Shields MD, et al. Controlled trial of nebulized albuterol in children younger than 2 years of age with acute asthma. Pediatrics 1992; 89: 133-137.
18. Kraemer R, Frey U, Sommer CW, Russi E. Short-term effect of albuterol, delivered via a new auxiliary device. in wheezy infants. Am Rev Respir Dis 1991; 144: 347-351.
19. Orlowski L, Zychowicz C, Migdal M, Gutkowski P. Effect of salbutamol on specific airway resistance in infants with a history of wheezing. Pediatr Pulmonol 1991; 10: 191-194.
20. Schweich PJ, Hurt TL, Walkley EI, Mullen N, Archibald LF. The use of nebulized albuterol in wheezing infants. Pediatr Emergency Care 1992; 8: 184-188.
21. O'Callaghan C, Milner AD, Swarbrick A. Nebulised salbutamol does have a protective effect on airways in children under 1 year old. Arch Dis Childhood 1988; 63: 479-483.
22. Prendiville A, Green S, Silverman M. Airway responsiveness in wheezy infants: evidence for functional beta adrenergic receptors. Thorax 1987; 42: 100-104.
23. Avital A, Godfrey S, Schachter J, Springer C. Protective effect of albuterol delivered via a spacer device (Babyhaler) against methacholine induced bronchoconstriction in young wheezy children. Pediatr Pulmonol 1994; 17: 281-284.
24. Clarke JR, Aston H, Silverman M. Delivery of salbutamol by metered dose inhaler and valved spacer to wheezy infants: effect on bronchial responsiveness. Arch Dis Childhood 1993; 69: 125-129.
25. Henderson AJ, Young S, Stick SM, Landau LI, LeSouef PN. Effect of salbutamol on histamine-induced bronchoconstriction in healthy infants. Thorax 1993; 48: 317-323.
26. Kraemer R, Birner P, Modelska K, Casaulta Aebischer C, Schoni MH. A new Baby Spacer device for aerosolised bronchodilator administration in infants with bronchopulmonary disease. Eur J Paediatr 1992; 151: 57-60.
27. Higham M, Sharara A, Wilson P, Jenkins R. Glendenning G, Ind P. Dose equivalence and bronchoprotective effects of salmeterol and salbutamol in asthma. Thorax 1997; 52: 975-980.
28. Verberne AA, Hop WC, Creyghton FB, et al. Airway responsiveness after a single dose of salmeterol and during four months of treatment in children with asthma. J Allergy Clin Immunol 1996; 97: 938-946.
29. Simons FE, Soni NR, Watson WT, Becker AB. Bronchodilator and bronchoprotective effects of salmaterol in young patients with asthma. J Allergy Clin Immunol 1992; 90: 840-846.